Erin McEvoy

This webinar discussed recent research on medical cannabis for conditions such as alcohol use disorder and chronic pain, directed for attendees of all backgrounds.

Here, we bring you our top four recent news articles, covering the cannabis and hemp beverage industry trends, cannabis hyperemesis syndrome, and research studies on brain function after cannabis use and on cannabis for inflammatory bowel disease.

This webinar explored trends, challenges, and marketing hurdles in the developing cannabis and hemp beverages industry.

The study measured children’s exposure to in-home cannabis smoke through biomarkers in urine samples.

The survey analyzed responses from CBD users and non-CBD users on their symptoms and quality of life.

In a special Roundtable discussion, the Veterans Action Council (VAC) invited Dr. Ethan Russo to discuss this syndrome, its growing prevalence, research, potential dangers, and possible solutions.

Here, we bring you our top four recent news articles, covering what's next in the DEA cannabis hearing, cannabis and opioids, the FDA's request for information on cannabis and pets, and Biden's pardons.

Two leading organizations, National Cannabis Roundtable and the US Cannabis Council are combining to create the new organization.

The partnership aims to support research, education, and patient access, aligning with both companies’ missions.

Adam Goers, SVP of Corporate Affairs for The Cannabist Company and the co-chair of the Coalition for Cannabis Scheduling Reform (CCSR), discusses the recent cancellation of the DEA cannabis rescheduling hearing, how this delay could be strategic and necessary to ensure a legitimate outcome that may benefit the interested parties seeking the rescheduling.

Before leaving the White House, President Biden granted clemency to individuals with nonviolent drug-related offenses.

Here, we bring you our top five recent news articles, covering delays in the cannabis rescheduling hearings, DoorDash’s expansion into hemp-derived products, and more.

The internship will provide hands-on experience in medical cannabis cultivation in the country’s expanding medical cannabis market.

In response to the recent announcement that the hearing concerning cannabis rescheduling had been delayed, Americans for Safe Access held a webinar discussing the impacts medical cannabis.

The facility will prioritize consumer safety, regulatory compliance, and high-quality cannabis products.

The Marijuana Policy Project examined national and state-level data on percentages of student cannabis use before and after cannabis laws were enacted.

Cannabis legalization and regulation was noted as an issue with longtime support of a majority of voters in the state.

Kentucky launched its medical cannabis program on January 1, 2025, allowing patients with qualifying conditions to apply for ID cards.

Sales of recreational cannabis began a few months ago in the state.

It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2024. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!

The study analyzed data from three adult age groups on daily or near daily cannabis and alcohol use.

In late January 2025 the survey will be sent to hemp producers in six states.

As we begin the year 2025, let’s review the most popular trends and topics in webinars covered by Cannabis Science and Technology in 2024.

Listen to a Noid Factoid from Yasha Kahn, co-founder of MCR Labs.

Check out the complete series from our Cannabis Analysis column.

A nationally representative survey revealed adolescent cannabis use trends for 2024.

The single-state companies involved in the merger are anticipated to continue their operations independently with the support of Vireo.

The patient-centered organization announced its 2025 plans for medical cannabis at the national level.

As bat guano becomes more commonly used in cannabis cultivation, a recent study highlights the negative effects that can come with using this type of fertilizer.

With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.